Getting serious about women’s heart health
Women experiencing chest pain or other symptoms of cardiac distress now have access to a specialist clinic just for them.
COVID-19: Everything you need to know about patient and visitor information.
Circulatory support research
The Alfred Heart Failure and Transplant service remains committed to ongoing research to improve the quality of lives for patients living with VADs and advancing the management of these patients for the best clinical outcomes.
The Heart Failure and Transplant service at The Alfred cares for approximately twenty five to thirty patients with ventricular assist devices (VADs) per year.
From the first clinical research trial of the Australian designed VentrAssist VAD in 2002 we remain involved in research of the newest ventricular assist devices, most recently the HeartMate III as part of an international multi-centre collaborative research trial.
Particular foci of research currently include ventricular assist device driveline infections, the haemodynamics of VADs with exercise, acute and long-term rehabilitation programmes for best physical outcomes post surgical implantation, quality of life of patients living with VADs and anticoagulation monitoring.
Dr Angeline Leet
Dr Angeline Leet is Deputy Director and Head of Echocardiography in the Department of Cardiology. She is a full time cardiologist in the Heart Failure & Transplant service at The Alfred.
Latest news
Coffee the secret to a long life
Drinking coffee could help you live longer according to world-first research by heart specialists at The Alfred.
Keeping hearts alive outside the body
A ground-breaking trial taking place across Australia and New Zealand could change the future of heart transplantation, potentially enabling up to 15 per cent more heart transplants to occur each year.